FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Admedus Gains CE Mark for Collagen Bioscaffold

March 13, 2019
A A

Admedus has been handed the CE Mark for its VascuCel collagen bioscaffold, a device used in a wide variety of vascular surgical procedures.

The device is strong but pliable and designed for good suturability. It is bioengineered using the company’s proprietary ADAPT technology and has been used with success in cardiac repairs and reconstructions.

The bioscaffold reduces the need for agents to stop bleeding due to its hemostasis capabilities and is ready for use off the shelf with no rinsing required.

View today's stories